Ikarian Capital’s Nuvalent NUVL Stock Holding History

Ikarian Capital’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-48,400	Closed	-$3.56M	–	168
2023 Q4	$3.56M	Buy	48,400 +47,877	+9,154%	+$2.96M	0.33%	70
2023 Q3	$2.4M	Buy	+523	New	+$23.2K	0.29%	76

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Ikarian Capital's NUVL Position: Q2 2026 in Review

Ikarian Capital sold out of Nuvalent (NUVL) in Q2 2026, closing a stake of 23,594 shares — an estimated $2.42M sold.

Ikarian Capital first reported a position in NUVL in Q2 2023 and held it in 9 quarters. The position peaked at $19M in Q4 2023. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Ikarian Capital reported no remaining Nuvalent position as of Q2 2026 after selling out during the quarter.
Ikarian Capital sold 23,594 Nuvalent shares in Q2 2026, an estimated $2.42M.
Ikarian Capital first reported a position in Nuvalent in Q2 2023 and held it in 9 quarters.
Ikarian Capital's Nuvalent position peaked at $19M in Q4 2023.
293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.